Equity Analysis /
United States of America

US : Mirum Pharmaceuticals, Inc. - MIRM | Livmarli Launch Analysis: Encouraging First Quarter

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    11 January 2022
    Published by